problems with glp 1 drugs Part 2 of a 3-Part Series; GLP-1 Medications for Weight Loss If GLP-1 Drugs Are Good

There simply hasnt been enough time to gather the kind of comprehensive, multi-generational pregnancy outcome data that exists for older medications

Not all rodent studies report elevated BP in response to GLP-1R agonism, but dose could be a discriminatory factor

doi: 10.2147/DMSO.S292742

Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: estimating the clinical profile and exploring intraclass differences

They influence appetite, satiety, gastric emptying, glucose regulation, insulin secretion, glucagon suppression, and other downstream metabolic pathways

Adverse event categories were drawn from prior literature, clinical knowledge, and a drug side-effect database, covering a wide range of symptoms from gastrointestinal to mental health issues